Good post QcontinuumCouldn't agree more. If this ceo is worth his salt then he should be able to increase revs organically. Buying revenue is what big pharma does. But they have the cash and the stock price to accommodate. Buying anything right now or merging makes no sense especially on the brink of US legalization before pending on the run up to the November election.
it simple, buy back shares now, and pay off the 2 million debt remaining will send us straight to 15 to 20c.
not doing something so obvious is red flag to me.